国邦医药
(605507)
| 流通市值：62.43亿 | | | 总市值：115.62亿 |
| 流通股本：3.02亿 | | | 总股本：5.59亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,475,049,795.21 | 1,341,322,469.77 | 2,038,939,796.1 | 2,094,158,957.59 |
| 应收票据及应收账款 | 813,152,400.86 | 770,060,685.12 | 623,314,494.42 | 532,156,693.33 |
| 应收账款 | 813,152,400.86 | 770,060,685.12 | 623,314,494.42 | 532,156,693.33 |
| 应收款项融资 | 532,014,447.86 | 471,751,677.36 | 364,086,112.08 | 432,764,570.09 |
| 预付款项 | 788,197,802.11 | 607,577,389.96 | 533,332,834.84 | 476,671,799.48 |
| 其他应收款合计 | 23,151,149.85 | 17,971,643.18 | 18,685,330.74 | 17,215,372.28 |
| 存货 | 1,307,066,160.41 | 1,335,905,071.73 | 1,463,145,984.74 | 1,368,556,845.48 |
| 其他流动资产 | 19,944,815.05 | 27,068,375.03 | 21,507,951.9 | 40,043,714.88 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 5,659,848,826.36 | 5,113,132,959.29 | 5,420,999,260.3 | 5,443,146,893.29 |
| 非流动资产: | | | | |
| 长期股权投资 | 99,824,560.47 | 100,673,448.32 | 100,431,494.29 | 101,126,769.04 |
| 其他非流动金融资产 | 20,000,000 | 20,000,000 | 20,000,000 | 20,000,000 |
| 投资性房地产 | 72,572,955.27 | 73,549,273.05 | 74,525,590.83 | 75,501,908.61 |
| 固定资产 | 3,998,838,604.53 | 3,915,253,076.52 | 3,707,286,342.26 | 3,693,392,649.45 |
| 在建工程 | 402,295,647.39 | 476,134,481.96 | 676,127,402.21 | 636,651,613.98 |
| 无形资产 | 353,844,722.74 | 354,630,792.18 | 356,238,169.52 | 358,847,188.24 |
| 商誉 | 25,487.37 | 25,487.37 | 25,487.37 | 25,487.37 |
| 长期待摊费用 | 7,566,276.62 | 7,683,774.05 | 7,680,858.65 | 8,023,413.97 |
| 递延所得税资产 | 7,004,797.17 | 10,058,487.89 | 16,964,866.31 | 7,778,437.58 |
| 其他非流动资产 | 11,565,133.07 | 15,819,504.86 | 20,483,139 | 17,140,987.39 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,973,538,184.63 | 4,973,828,326.2 | 4,979,763,350.44 | 4,918,488,455.63 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 10,633,387,010.99 | 10,086,961,285.49 | 10,400,762,610.74 | 10,361,635,348.92 |
| 流动负债: | | | | |
| 短期借款 | 325,228,569.44 | 460,328,485.73 | 458,169,408.34 | 482,694,130.56 |
| 交易性金融负债 | - | 64,746 | 359,548.73 | - |
| 应付票据及应付账款 | 1,652,153,109.63 | 1,207,742,952.1 | 1,507,058,205.13 | 1,714,611,824.08 |
| 其中：应付票据 | 1,042,499,585.57 | 585,784,714.59 | 886,450,888.97 | 1,090,789,223.93 |
| 应付账款 | 609,653,524.06 | 621,958,237.51 | 620,607,316.16 | 623,822,600.15 |
| 合同负债 | 45,430,068.51 | 50,812,467.55 | 54,650,607.27 | 55,848,631.5 |
| 应付职工薪酬 | 58,958,764.62 | 74,263,162.43 | 50,157,760.57 | 82,517,420.72 |
| 应交税费 | 51,684,218.22 | 37,913,446.56 | 30,185,239.97 | 34,227,177.88 |
| 其他应付款合计 | 45,969,651.88 | 40,780,806.5 | 41,273,029.45 | 46,219,474.34 |
| 应付股利 | 621,951.39 | 621,951.39 | 621,951.39 | 621,951.39 |
| 一年内到期的非流动负债 | 380,153,125 | 385,153,125 | 28,875,166.67 | 28,875,166.67 |
| 其他流动负债 | 3,246,463.39 | 3,347,955.12 | 4,274,688.97 | 4,627,905.23 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,562,823,970.69 | 2,260,407,146.99 | 2,175,003,655.1 | 2,449,621,730.98 |
| 非流动负债: | | | | |
| 长期借款 | 203,710,732.79 | 230,026,819.45 | 584,806,944.43 | 451,700,000 |
| 递延收益 | 13,608,359.98 | 13,926,248.03 | 11,191,855.8 | 11,799,963.18 |
| 递延所得税负债 | 7,384,867.65 | 6,644,694.63 | 21,048,596.01 | 11,324,865.41 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 224,703,960.42 | 250,597,762.11 | 617,047,396.24 | 474,824,828.59 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,787,527,931.11 | 2,511,004,909.1 | 2,792,051,051.34 | 2,924,446,559.57 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 558,823,500 | 558,823,500 | 558,823,500 | 558,823,500 |
| 资本公积 | 3,604,674,635.4 | 3,607,088,514.33 | 3,607,088,514.33 | 3,607,088,514.33 |
| 减:库存股 | 1,479,452.95 | 99,526,828.93 | 27,585,916 | - |
| 盈余公积 | 183,831,416.84 | 183,831,416.84 | 183,831,416.84 | 183,831,416.84 |
| 未分配利润 | 3,494,520,824.37 | 3,320,233,793 | 3,281,021,593.55 | 3,082,290,465.23 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,840,370,923.66 | 7,570,450,395.24 | 7,603,179,108.72 | 7,432,033,896.4 |
| 少数股东权益 | 5,488,156.22 | 5,505,981.15 | 5,532,450.68 | 5,154,892.95 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,845,859,079.88 | 7,575,956,376.39 | 7,608,711,559.4 | 7,437,188,789.35 |
| 负债和股东权益合计 | 10,633,387,010.99 | 10,086,961,285.49 | 10,400,762,610.74 | 10,361,635,348.92 |
| 公告日期 | 2024-10-19 | 2024-08-30 | 2024-04-16 | 2024-04-16 |
| 审计意见(境内) | | | | 标准无保留意见 |